Blue Water Biotech EBIT

As of the most recent data (June 2026), BWV shows a EBIT of $-10M. That compares with $-54M in the prior-year period — up 81.5% year over year. That is below the sector sector average of $-6.4M. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BWV's EBIT is now $-10M (was $-54M) — a 81.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Blue Water Biotech is outperforming or lagging.

The its sector sector average EBIT is about $-6.4M. Blue Water Biotech is at $-10M, which is lower that average. That is roughly 56.5% below the sector mean. Use the comparison chart on this page to see how BWV stacks up against individual peers as well.

Tracking BWV's ebit over time shows whether Blue Water Biotech is scaling, shrinking, or reshaping that part of the business. The current reading is $-10M That compares with $-54M in the prior-year period — up 81.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has Blue Water Biotech's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-10M) with ownership activity and broader fundamentals.